{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:11:57Z","timestamp":1790856717330,"version":"4.1.0"},"reference-count":46,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP17K16265"],"award-info":[{"award-number":["JP17K16265"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP20K17554"],"award-info":[{"award-number":["JP20K17554"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["19ck0106332h0003"],"award-info":[{"award-number":["19ck0106332h0003"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Cancer Control from the Japan Agency Medical Research","award":["JP17K16265"],"award-info":[{"award-number":["JP17K16265"]}]},{"name":"Innovative Cancer Control from the Japan Agency Medical Research","award":["JP20K17554"],"award-info":[{"award-number":["JP20K17554"]}]},{"name":"Innovative Cancer Control from the Japan Agency Medical Research","award":["19ck0106332h0003"],"award-info":[{"award-number":["19ck0106332h0003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Outcomes of pediatric hepatoblastoma (HBL) have improved, but refractory cases still occur. More effective and safer drugs are needed that are based on molecular mechanisms. A disintegrin and metalloproteases (ADAMs) are expressed with high frequency in various human carcinomas and play an important role in cancer progression. In this study, we analyzed expression of ADAMs in HBL with a cDNA microarray dataset and found that the expression level of ADAM32 is particularly high. To investigate the role of ADAM32 in cancer, forced expression or knockdown experiments were conducted with HepG2 and HBL primary cells. Colony formation, cell migration and invasion, and cell viability were increased in HepG2 expressing ADAM32, whereas knockdown of ADAM32 induced a decrease in these cellular functions. Quantitative RT-PCR demonstrated an association between ADAM32 expression and the expression of genes related to cancer stem cells and epithelial\u2013mesenchymal transition (EMT), suggesting a role of ADAM32 in cancer stemness and EMT. Furthermore, knockdown of ADAM32 increased cisplatin-induced apoptosis, and this effect was attenuated by a caspase-8 inhibitor, suggesting that ADAM32 plays a role in extrinsic apoptosis signaling. We conclude that ADAM32 plays a crucial role in progression of HBL, so it might be a promising molecular target in anticancer therapy.<\/jats:p>","DOI":"10.3390\/cancers14194732","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T20:58:47Z","timestamp":1664398727000},"page":"4732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy"],"prefix":"10.3390","volume":"14","author":[{"given":"Takahiro","family":"Fukazawa","sequence":"first","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-4197","authenticated-orcid":false,"given":"Keiji","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2289-9320","authenticated-orcid":false,"given":"Masami","family":"Kanawa","sequence":"additional","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-214X","authenticated-orcid":false,"given":"Nobuyuki","family":"Hirohashi","sequence":"additional","affiliation":[{"name":"Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-5037","authenticated-orcid":false,"given":"Eiso","family":"Hiyama","sequence":"additional","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1470-2045(00)00018-8","article-title":"SIOPEL trials using preoperative chemotherapy in hepatoblastoma","volume":"1","author":"Perilongo","year":"2000","journal-title":"Lancet Oncol."},{"key":"ref_2","first-page":"293","article-title":"Pediatric hepatoblastoma: Diagnosis and treatment","volume":"3","author":"Hiyama","year":"2014","journal-title":"Transl. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.12688\/f1000research.12239.1","article-title":"Hepatoblastoma: Current understanding, recent advances, and controversies","volume":"7","author":"Czauderna","year":"2018","journal-title":"F1000Research"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jpedsurg.2016.09.038","article-title":"Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol","volume":"51","author":"Hiyama","year":"2016","journal-title":"J. Pediatr. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e27383","DOI":"10.1002\/pbc.27383","article-title":"Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation","volume":"65","author":"Uchida","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: A consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00383-013-3399-0","article-title":"A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: Experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT)","volume":"29","author":"Hiyama","year":"2013","journal-title":"Pediatr. Surg. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","article-title":"Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: Report from the JPLT","volume":"27","author":"Hishiki","year":"2011","journal-title":"Pediatr. Surg. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","article-title":"Targeted cancer therapy","volume":"432","author":"Sawyers","year":"2004","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2013.11.004","article-title":"Molecularly targeted cancer therapy: Some lessons from the past decade","volume":"35","author":"Huang","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_11","first-page":"269","article-title":"Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene","volume":"59","author":"Koch","year":"1999","journal-title":"Cancer Res."},{"key":"ref_12","first-page":"901","article-title":"Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma","volume":"7","author":"Takayasu","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3748\/wjg.v22.i2.823","article-title":"Targeting Wnt\/beta-catenin pathway in hepatocellular carcinoma treatment","volume":"22","author":"Vilchez","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/hep.27347","article-title":"Mutational landscape of hepatoblastoma goes beyond the Wnt-beta-catenin pathway","volume":"60","author":"Han","year":"2014","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3892\/ol.2016.4789","article-title":"Genome-wide analysis of DNA methylation in hepatoblastoma tissues","volume":"12","author":"Cui","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1349-7006.2007.00434.x","article-title":"ADAMs in cancer cell proliferation and progression","volume":"98","author":"Mochizuki","year":"2007","journal-title":"Cancer Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1078-0432.CCR-08-1585","article-title":"Role of ADAMs in cancer formation and progression","volume":"15","author":"Duffy","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/15384047.2016.1177684","article-title":"The ADAMs family of proteases as targets for the treatment of cancer","volume":"17","author":"Mullooly","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1083\/jcb.104.1.141","article-title":"Identification and purification of a sperm surface protein with a potential role in sperm-egg membrane fusion","volume":"104","author":"Primakoff","year":"1987","journal-title":"J. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/356248a0","article-title":"A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion","volume":"356","author":"Blobel","year":"1992","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/bies.1088","article-title":"Fertilin beta and other ADAMs as integrin ligands: Insights into cell adhesion and fertilization","volume":"23","author":"Evans","year":"2001","journal-title":"Bioessays"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrm1548","article-title":"ADAMs: Key components in EGFR signalling and development","volume":"6","author":"Blobel","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yumoto, N., Wakatsuki, S., Kurisaki, T., Hara, Y., Osumi, N., Frisen, J., and Sehara-Fujisawa, A. (2008). Meltrin beta\/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003322"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1055\/s-0038-1660479","article-title":"A disintegrin and metalloproteases (ADAMs) in cardiovascular, metabolic and inflammatory diseases: Aspects for theranostic approaches","volume":"118","author":"Weber","year":"2018","journal-title":"Thromb. Haemost."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)64567-1","article-title":"Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome","volume":"157","author":"Weber","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2022.04.035","article-title":"Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults","volume":"77","author":"Sumazin","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1538-7445.AM2019-1586","article-title":"ADAM32 is amplifed in a wide range of malignancy","volume":"79","author":"Rajan","year":"2019","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"170105","DOI":"10.1038\/sdata.2017.105","article-title":"RefEx, a reference gene expression dataset as a web tool for the functional analysis of genes","volume":"4","author":"Ono","year":"2017","journal-title":"Sci. Data"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Naito, Y., Yoshimura, J., Morishita, S., and Ui-Tei, K. (2009). siDirect 2.0: Updated software for designing functional siRNA with reduced seed-dependent off-target effect. BMC Bioinform., 10.","DOI":"10.1186\/1471-2105-10-392"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Fukazawa, T., Tanimoto, K., Shrestha, L., Imura, T., Takahashi, S., Sueda, T., Hirohashi, N., Hiyama, E., and Yuge, L. (2019). Simulated microgravity enhances CDDP-induced apoptosis signal via p53-independent mechanisms in cancer cells. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219363"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"EMBO J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1158\/1078-0432.CCR-04-0337","article-title":"Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells","volume":"10","author":"Noguchi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1038\/sj.onc.1209627","article-title":"Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation","volume":"25","author":"Komiya","year":"2006","journal-title":"Oncogene"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3892\/ijo.2013.2034","article-title":"MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer","volume":"43","author":"Luo","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/carcin\/bgaa010","article-title":"GLIS1, a novel hypoxia-inducible transcription factor, promotes breast cancer cell motility via activation of WNT5A","volume":"41","author":"Shimamoto","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1200\/JCO.19.01067","article-title":"Outcome and late complications of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol","volume":"38","author":"Hiyama","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_38","unstructured":"Musick, S.R., Smith, M., Rouster, A.S., and Babiker, H.M. (2022). Hepatoblastoma, StatPearls Publishing."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gene.2018.10.051","article-title":"Long non-coding RNA THOR promotes liver cancer stem cells expansion via beta-catenin pathway","volume":"684","author":"Cheng","year":"2018","journal-title":"Gene"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pandit, H., Li, Y., Li, X., Zhang, W., Li, S., and Martin, R.C.G. (2018). Enrichment of cancer stem cells via beta-catenin contributing to the tumorigenesis of hepatocellular carcinoma. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4683-0"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/abbs\/gmv134","article-title":"beta-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma","volume":"48","author":"Jiang","year":"2016","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.sempedsurg.2016.09.002","article-title":"Malignant tumors of the liver in children","volume":"25","author":"Aronson","year":"2016","journal-title":"Semin. Pediatr. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/jcs.00739","article-title":"Apoptosis\u2014The p53 network","volume":"116","author":"Haupt","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_44","first-page":"85","article-title":"Caspase-8 in apoptosis: The beginning of \u201cthe end\u201d?","volume":"50","author":"Kruidering","year":"2000","journal-title":"IUBMB Life"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/sj.cdd.4402101","article-title":"ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death","volume":"14","author":"Schulte","year":"2007","journal-title":"Cell Death Differ."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/19\/4732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:41:19Z","timestamp":1760143279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/19\/4732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":46,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["cancers14194732"],"URL":"https:\/\/doi.org\/10.3390\/cancers14194732","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]}}}